Business, energy, technology, markets and global industry news from Business News Today

transcranial magnetic stimulation

Medical Devices & Diagnostics

FDA clears Zeta’s robotic TMS system, but the real test begins inside busy clinics

Zeta Surgical wins FDA clearance for its robotic TMS system, advancing automated coil positioning and motion compensation in neuromodulation clinics.

Read More
Pharma & Biotech

Why Kadima is suing NRx Pharmaceuticals over the failed HOPE Therapeutics acquisition

The legal fight over Kadima Neuropsychiatry Institute tests NRx Pharmaceuticals’ acquisition discipline, financing credibility and evolving interventional psychiatry strategy.

Read More
Pharma & Biotech

Why HOPE Therapeutics’ first Zeta-guided TMS patients matter for psychiatry care

NRx’s HOPE Therapeutics begins Zeta-guided TMS treatments, bringing AI-powered image guidance into outpatient depression care workflows.

Read More
Medical Devices & Diagnostics

FDA clears compact SPRY TMS system: can Soterix Medical disrupt the depression treatment market?

Soterix Medical wins FDA clearance for SPRY TMS in treatment-resistant major depression. What the clearance means for the neuromodulation market. Read the analysis.

Read More
Pharma & Biotech

Can ketamine treatment clinics like Serenity redefine psychiatric care delivery in suburban America?

Serenity expands ketamine therapy in Florida. Find out how this signals a shift in psychiatric care access and what clinicians are watching next.

Read More